Sampson, J. H., Friedman, A. H., Reardon, D. A., Friedman, H., Provenzale, J. M., Bigner, D. D., … Puri, R. K. (2004). Convection-enhanced delivery of IL13-PE38QQR in malignant glioma: Comparison of observed and predicted drug distribution. In NEURO-ONCOLOGY (Vol. 6, pp. 381–382). Toronto, CANADA: DUKE UNIV PRESS.

Sampson, J. H., A. H. Friedman, D. A. Reardon, H. Friedman, J. M. Provenzale, D. D. Bigner, M. Brady, et al. “Convection-enhanced delivery of IL13-PE38QQR in malignant glioma: Comparison of observed and predicted drug distribution.” In NEURO-ONCOLOGY, 6:381–82. DUKE UNIV PRESS, 2004.

Sampson JH, Friedman AH, Reardon DA, Friedman H, Provenzale JM, Bigner DD, et al. Convection-enhanced delivery of IL13-PE38QQR in malignant glioma: Comparison of observed and predicted drug distribution. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 381–2.

Sampson, J. H., et al. “Convection-enhanced delivery of IL13-PE38QQR in malignant glioma: Comparison of observed and predicted drug distribution.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 381–82.

Sampson JH, Friedman AH, Reardon DA, Friedman H, Provenzale JM, Bigner DD, Brady M, Raghavan R, Pedain C, Archer G, Lally-Batts D, McGehee S, Tourt-Uhlig S, Grahn A, Dul JL, Croteau D, Sherman JW, Puri RK. Convection-enhanced delivery of IL13-PE38QQR in malignant glioma: Comparison of observed and predicted drug distribution. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 381–382.